Skip to content
pharmaceutical daily

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • News by region
    • East and Central Asia
    • Europe
    • Latin America
    • Middle East and North Africa
    • North America
  • Pharma Business
  • My Pharmaceutical
  • About us
    • Media Kit
    • Privacy Policy
  • Contact

Tag: Erleada

Trovagene expands the use of Onvansertib

Trovagene has expanded the use of Onvansertib to enable it for combination therapies with anti-androgen drugs, like Zytiga, Xtandi and Erledea to treat castrate-resistant prostate cancer.

Published January 23, 2019
Categorized as news Tagged abiraterone acetate, Erleada, Onvansertib, Trovagene, Xtandi, Zytiga




pharmaceutical daily
Proudly powered by WordPress.